You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years
|
|---|---|
| Published in |
BMC Geriatrics, January 2005
|
| DOI | 10.1186/1471-2318-5-3 |
| Pubmed ID | |
| Authors |
Martin R Farlow, Mary L Lilly, for the ENA713 B352 Study Group |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 4% |
| United States | 2 | 4% |
| United Kingdom | 1 | 2% |
| Unknown | 44 | 90% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 18% |
| Student > Postgraduate | 5 | 10% |
| Professor > Associate Professor | 5 | 10% |
| Researcher | 4 | 8% |
| Student > Ph. D. Student | 3 | 6% |
| Other | 10 | 20% |
| Unknown | 13 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 14 | 29% |
| Psychology | 3 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
| Chemistry | 2 | 4% |
| Neuroscience | 2 | 4% |
| Other | 7 | 14% |
| Unknown | 18 | 37% |